Stockreport

Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer [Yahoo! Finance]

Kairos Pharma, Ltd.  (KAPA) 
PDF LOS ANGELES, September 11, 2025 BUSINESS WIRE )--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer ther [Read more]